SCHEMBL29960294

SCHEMBL29960294

O=[N+]([O-])CC1CCOc2ccsc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29960243 0.77
SCHEMBL29960765 0.76 TAAR1 (0.41)
Hydrochloric Acid SCHEMBL29960613 0.75 TAAR1 (0.41)
SCHEMBL29960441 0.72
SCHEMBL29960339 0.72
Hydrochloric Acid SCHEMBL29960779 0.72 TAAR1 (0.44)
Hydrochloric Acid SCHEMBL29959968 0.72 TAAR1 (0.44)
SCHEMBL29960744 0.69 MAP3K14 (0.37)
SCHEMBL29960433 0.68 TAAR1 (0.41)
SCHEMBL10025872 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed